Mayne Pharma Group Ltd (Mayne Pharma), is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company offers products such as astrix capsules, Eryc capsules, kapanol capsules, lozanoc capsules, amethia tablets, amiodarone hydrochloride tablets, azurette tablets, budesonide capsules, camila tablets and clonidine transdermal patches, among others. It also offers contract development and CDMO services such as pharmaceutical development, analytical testing and commercial manufacturing. The company operates in Australia and the US, the UK and Canada. Mayne Pharma is headquartered in Adelaide, South Australia, Australia.
Headquarters
Australia
Address
1538 Main North Rd, Adelaide, South Australia, 5106
Website
www.maynepharma.com
Telephone
61 8 82092666
No of Employees
900
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
MYX (ASX)
Revenue (2022)
$132.0M
20.7%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
141.7%
(2022 vs 2021)
Market Cap*
$388.2M
Net Profit Margin (2022)
XYZ
134.5%
(2022 vs 2021)
* As of and is in US$
Mayne Pharma Group Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Astrix Capsules | Contract Services | Astrix |
| Eryc Capsules | Product Development | Doryx |
| Kapanol Capsules | Kadian | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In September, the company's subsidiary entered into an asset purchase agreement to acquire the global rights to RHOFADE from Novan, Inc. and EPI Health, LLC. |
| 2023 | Divestiture | In April, the company sold its US retail generics portfolio to Dr Reddy’s Laboratories. |
| 2022 | Contracts/Agreements | In December, the company signed an exclusive license agreement with TherapeuticsMD, Inc for three branded women’s health products and a portfolio of prenatal vitamins in the US. |
Competitor Comparison
| Key Parameters | Mayne Pharma Group Ltd | CSL Ltd | Sigma Healthcare Ltd | Cryosite Ltd | IDT Australia Ltd |
|---|---|---|---|---|---|
| Headquarters | Australia | Australia | Australia | Australia | Australia |
| City | Adelaide | Melbourne | Melbourne | Sydney | Melbourne |
| State/Province | South Australia | Victoria | Victoria | New South Wales | Victoria |
| No. of Employees | 900 | 32,065 | 156 | 34 | 156 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Frank Condella | Chairman | Executive Board | 2021 | 68 |
| Shawn Patrick O’Brien | Chief Executive Officer; Managing Director; Director | Executive Board | 2022 | - |
| Aaron Gray | Chief Financial Officer | Senior Management | 2022 | - |
| Brant Schofield | Executive Vice President - Corporate Development | Senior Management | - | - |
| Laura Loftus | Secretary; Associate General Counsel | Senior Management | 2020 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward